Column Capital Advisors, LLC Oncternal Therapeutics, Inc. Transaction History

Column Capital Advisors, LLC

  • $1.92 Billion
  • Q3 2023

A detailed history of Column Capital Advisors, LLC transactions in Oncternal Therapeutics, Inc. stock. As of the latest transaction made, Column Capital Advisors, LLC holds 1,450 shares of ONCT stock, worth $2,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,450
Previous 1,450 -0.0%
Holding current value
$2,218
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
BUY
$0.86 - $22.2 $1,247 - $32,190
1,450 New
1,450 $1,000

Others Institutions Holding ONCT

# of Institutions
3
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $84.9M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Column Capital Advisors, LLC Portfolio

Follow Column Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email